Due to their specificity, efficiency, and ease of programming, CRISPR-associated nucleases are popular tools for genome editing. On the genomic scale, these nucleases still show considerable off-target activity though, posing a serious obstacle to the development of therapies. Off targeting is often minimized by choosing especially high-specificity guide sequences, based on algorithms that codify empirically determined off-targeting rules. A lack of mechanistic understanding of these rules has so far necessitated their ad hoc implementation, likely contributing to the limited precision of present algorithms. To understand the targeting rules, we kinetically model the physics of guide-target hybrid formation. Using only four parameters, our ...
The adaptation of the CRISPR-Cas9 system as a genome editing technique has generated much excitement...
CRISPR-Cas9 is the state-of-the-art technology for editing and manipulating nucleic acids. However, ...
Engineered SpCas9s and AsCas12a cleave fewer off-target genomic sites than wild-type (wt) Cas9. Howe...
Due to their specificity, efficiency, and ease of programming, CRISPR-associated nucleases are popul...
The specificity of CRISPR/Cas9 genome editing is largely determined by the sequences of guide RNA (g...
CRISPR-Cas effector complexes recognise nucleic acid targets by base pairing with their crRNA which ...
CRISPR/Cas9 is a versatile genome-editing technology that is widely used for studying the functional...
Cas12a is a type V class 2 CRISPR-Cas nuclease that has recently been repurposed as a precision DNA-...
CRISPR/Cas9 genome editing technology is the frontier of life science research. They have been used ...
CRISPR-Cas effector complexes enable the defense against foreign nucleic acids and have recently bee...
Genome editing mediated by engineered nucleases, including Transcription Activator-Like Effector Nuc...
The S. pyogenes (Sp) Cas9 endonuclease is an important gene-editing tool. SpCas9 is directed to targ...
Background: The success of the CRISPR/Cas9 genome editing technique depends on the choice of the gui...
Abstract Background Recent experimental efforts of CRISPR-Cas9 systems have shown that off-target bi...
<div><p>The adaptation of the CRISPR-Cas9 system as a genome editing technique has generated much ex...
The adaptation of the CRISPR-Cas9 system as a genome editing technique has generated much excitement...
CRISPR-Cas9 is the state-of-the-art technology for editing and manipulating nucleic acids. However, ...
Engineered SpCas9s and AsCas12a cleave fewer off-target genomic sites than wild-type (wt) Cas9. Howe...
Due to their specificity, efficiency, and ease of programming, CRISPR-associated nucleases are popul...
The specificity of CRISPR/Cas9 genome editing is largely determined by the sequences of guide RNA (g...
CRISPR-Cas effector complexes recognise nucleic acid targets by base pairing with their crRNA which ...
CRISPR/Cas9 is a versatile genome-editing technology that is widely used for studying the functional...
Cas12a is a type V class 2 CRISPR-Cas nuclease that has recently been repurposed as a precision DNA-...
CRISPR/Cas9 genome editing technology is the frontier of life science research. They have been used ...
CRISPR-Cas effector complexes enable the defense against foreign nucleic acids and have recently bee...
Genome editing mediated by engineered nucleases, including Transcription Activator-Like Effector Nuc...
The S. pyogenes (Sp) Cas9 endonuclease is an important gene-editing tool. SpCas9 is directed to targ...
Background: The success of the CRISPR/Cas9 genome editing technique depends on the choice of the gui...
Abstract Background Recent experimental efforts of CRISPR-Cas9 systems have shown that off-target bi...
<div><p>The adaptation of the CRISPR-Cas9 system as a genome editing technique has generated much ex...
The adaptation of the CRISPR-Cas9 system as a genome editing technique has generated much excitement...
CRISPR-Cas9 is the state-of-the-art technology for editing and manipulating nucleic acids. However, ...
Engineered SpCas9s and AsCas12a cleave fewer off-target genomic sites than wild-type (wt) Cas9. Howe...